Arizona-based Aviant Healthcare is proposing a new spin on the surgical instrument supply chain: It wants to change how medical devices are delivered to improve the pricing imbalance that exists for single-use, sterile surgical equipment. In short, it wants to take marketing and sales costs out of the equation.
Aviant says it’s developing a line of inexpensive, disposable surgery products that are interoperable with hospitals’ existing trauma, orthopedic spine sets.
While many cost savings on disposable surgical products are on the back end, from rebates and compliance-based savings, Aviant says its business model is based on cutting the price up front. Here’s the company’s claim:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
All of this, with pricing based on the real cost of manufacturing – which offers up to 75% savings from current OEM pricing and up to 30% savings from reprocessed or other generic products.
The startup has plans to raise $10 million, according to a regulatory filing; thus far, it’s brought in about $811,000 from 12 investors.
